Complement in transplant rejection: Diagnostic and mechanistic considerations

Springer Seminars in Immunopathology

Volumn 25, Issue 2, 2003, Pages 181-197

  Baldwin, William M ^a   Ota, Hirofumi ^a,b   Rodriguez, E Rene ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAISEIKAI SENRI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; B LYMPHOCYTE; BLOOD GROUP INCOMPATIBILITY; CELL INTERACTION; CHEMOTAXIS; COMPLEMENT ACTIVATION; DIAGNOSTIC PROCEDURE; ENDOTHELIUM CELL; GRAFT REJECTION; GRANULOCYTE; HISTOCOMPATIBILITY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; INFLAMMATION; MOLECULAR MECHANICS; MONOCYTE; ORGAN DONOR; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; B-LYMPHOCYTES; COMPLEMENT ACTIVATION; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; GRAFT REJECTION; HUMANS; REPERFUSION INJURY; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS;

EID: 0141686876     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00281-003-0133-3     Document Type: Article

References (100)

1. Andrews PA, Finn JE, Lloyd CM, et al (1995) Expression and tissue localization of donor-specific complement C3 synthesized in human renal allografts. Eur J Immunol 25: 1087
2. Baldwin WM, III, Samaniego-Picota M, Kasper EK, et al (1999) Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes. Transplantation 68: 894
3. Baldwin WM III, Qian Z, Ota H, et al (2000) Complement as a mediator of vascular inflammation and activation in allografts. J Heart Lung Transpl 19: 723
4. Baldwin WM, III, Flavahan NA, Fairchild RL (2002) Integration of complement and leukocytes in response to allotransplantation. Curr Opin Transplant 7: 92
5. Barilla-LaBarca ML, Liszewski MK, Lambris JD, et al (2002) Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells. J Immunol 168: 6298
6. Behr TM, Feucht HE, Richter K, et al (1999) Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant 18: 904
7. Benzaquen LR, Nicholson-Weller A, Halperin JA (1994) Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. J Exp Med 179: 985
8. Bless NM, Tojo SJ, Kawarai H, et al (1998) Differing patterns of P-selectin expression in lung injury. Am J Pathol 153: 1113
9. Bohmig GA, Regele H, Saemann MD, et al (2000) Role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graft. Am J Kidney Dis 35: 667
10. Bohmig GA, Exner M, Habicht A, et al (2002) Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 13: 1091
11. Botto M, Dell'Agnola C, Bygrave AE, et al (1998) Homozygous Clq deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19: 56-59
12. Brauer RB, Baldwin WM, III, Ibrahim S, et al (1995) The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat. Transplantation 59: 288
13. Brooimans RA, Stegmann AP, Dorp WT van, et al (1991) Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest 88: 379
14. Carney DF, Koski CL, Shin ML (1985) Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9. J Immunol 134: 1804-1809
15. Celi A, Pellegrini G, Lorenzet R, et al (1994) P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A 91: 8767
16. Collard CD, Vakeva A, Morrissey MA, et al (2000) Complement activation after oxidative stress: role of the lectin complement pathway. Am J Pathol 156: 1549
17. Collins AB, Schneeberger EE, Pascual MA, et al (1999) Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 10: 2208
18. Couser WG, Pippin JW, Shankland SJ (2001) Complement (C5b-9) induces DNA synthesis in rat mesangial cells in vitro. Kidney Int 59: 905
19. Crespo M, Pascual M, Tolkoff-Rubin N, et al (2001) Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation 71: 652
20. D'Alessandro AM, Pirsch JD, Knechtle SJ, et al (1998) Living unrelated renal donation: the University of Wisconsin experience. Surgery 124: 604
21. Dalmasso AP, Vercellotti GM, Platt JL, et al (1991) Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation 52: 530
22. Dempsey PW, Allison MED, Akkaraju S, et al (1996) C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity. Science 271: 348
23. DiScipio RG, Daffern PJ, Jagels MA, et al (1999) A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. J Immunol 162: 1127
24. Du Clos TW (2000) Function of C-reactive protein. Ann Med 32: 274
25. Fearon DT, Locksley RM (1996) The instructive role of innate immunity in the acquired immune response. Science 272: 50
26. Fearon DT, Carroll MC (2000) Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol 18: 393
27. Feucht HE, Felber E, Gokel MJ, et al (1991) Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 86: 464
28. Feucht HE, Schneeberger H, Hillebrand G, et al (1993) Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 43: 1333
29. Feucht HE, Opelz G, (1996) The humoral immune response towards HLA class II determinants in renal transplantation. Kidney Int 50: 1464
30. Foreman KE, Vaporciyan AA, Bonish BK, et al (1994) C5a-induced expression of P-selectin in endothelial cells. J Clin Invest 94: 1147
31. Gasque P, Fontaine M, Morgan BP (1995) Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J Immunol 154: 4726
32. Gerard C, Gerard NP (1994) C5a anaphylatoxin and its seven transmembrane-segment receptor. Annu Rev Immunol 12: 775
33. Gershov G, Kim S, Brot N, et al (2000) C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 192: 1353
34. Griselli M, Herbert J, Hutchinson WL, et al (1999) C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 190: 1733
35. Halloran PF, Wadgymar A, Ritchie S, et al (1990) The significance of the anti-class I antibody response: I. Clinical and pathological features of anti-class I-mediated rejection. Transplantation 49: 85
36. Halloran PF, Schlaut J, Solez K, et al (1992) The significance of the anti-class I response: II. Clinical and pathological features of renal transplams with anti-class I-like antibody. Transplantation 53: 550
37. Hattori R, Hamilton KK, McEver RP, et al (1989) Complement proteins C5b-C9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem 264: 9053
38. Haviland DL, McCoy RL, Whitehead WT, et al (1995) Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J Immunol 154: 1861
39. Johnson E, Hetland G (1988) Mononuclear phagocytes have the potential to synthesize the complete functional complement system. Scand J Immunol 27: 489
40. Jordan SC, Tyan D, Czer L, et al (1998) Immunomodulatory actions of intravenous immunoglobulin (IVIG): potential applications in solid organ transplant recipients. Pediatr Transplant 2: 92
41. Kilgore KS, Friedrichs GS, Homeister JW. et al Cardiosase Res (1994) The complement system in myocardial ischaemia/reperfusion injury. 28: 437
42. Kilgore KS, Shen JP, Miller BF, et al (1995) Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. J Immunol 155: 1434
43. Kilgore KS, Flory CM, Miller BF, et al (1996) The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells. Am J Pathol 149: 953
44. Kilgore KS, Schmid E, Shanley TP, et al (1997) Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Am J Pathol 150: 2019
45. Kissmeyer-Nielsen F, Olsen S, Petersen VP, et al (1962) Hyperacute rejection of kidney allografts associated with pre-existing humoral antibodies against donor cells. Lancet II: 662
46. Lafond-Walker A, Chen CL, Augustine S, et al (1997) Inducible nitric oxide synthase expression in coronary arteries of transplanted human hearts with accelerated graft arteriosclerosis. Am J Pathol 151: 919
47. Lones MA, Czer LS, Trento A, et al (1995) Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients. J Heart Lung Transplant 14: 151
48. Maroko PR, Carpenter CD, Chiariello M, et al (1978) Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J Clin Invest 61: 661
49. Marsh JE, Farmer CK, Jurcevic S, et al (2001) The allogeneic T and B cell response is strongly dependent on complement components C3 and C4. Transplantation 72: 1310
50. Marth T, Kelsall BL (1997) Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med 185: 1987
51. Mauiyyedi S, Colvin RB (2002) Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens 11: 609
52. McManus BM, Horley KJ, Wilson JE, et al (1995) Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathy. Am J Pathol 147: 293
53. Mevorach D, Mascarenhas JO, Gershov D, et al (1998) Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 188: 2313
54. Mevorach D, Zhou JL, Song X, et al (1998) Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 188: 387
55. Montgomery RA, Zachary AA, Racusen LC, et al (2000) Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 70: 887
56. Morgan BP, Dankert JR, Esser AF (1987) Recovery of human neutrophils from complement attack: Removal of the membrane attack complex by endocytosis and exocytosis. J Immunol 138: 246
57. Morgan BP, Walport MJ (1991) Complement deficiency and diseases. Immunol Today 12: 301
58. Mulligan MS, Schmid E, Till GO, et al (1997) C5a-dependent up-regulation in vivo of lung vascular P-selectin. J Immunol 158: 1857
59. Nakashima S, Qian Z, Rahimi S, et al (2002) Membrane attack complex contributes to destruction of vascular integrity in acute lung allograft rejection. J Immunol 169: 4620
60. Nataf S, Davoust N, Ames RS, et al (1999) Human T cells express the C5a receptor and are chemoattracted to C5a. J Immunol 162: 4018
61. Nauta AJ, Trouw LA, Daha MR, et al (2002) Direct binding of Clq to apoptotic cells and cell blebs induces complement activation. Eur J Immunol 32: 1726-1736
62. Navratil JS, Watkins SC, Wisnieski JJ, et al (2001) The globular heads of Clq specifically recognize surface blebs of apoptotic vascular endothelial cells. J Immunol 166: 3231
63. Nickeleit V, Zeiler M, Gudat F, et al (2002) Detection of the complement degradation product c4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 13: 242
64. Niculescu F, Badea T, Rus H (1999) Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase. Atherosclerosis 142: 47
65. Niculescu F, Rus H (2001) Mechanisms of signal transduction activated by sublytic assembly of terminal complement complexes on nucleated cells. Immunol Res 24: 191
66. Ollert MW, Kadlec JV, David K, et al (1994) Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps. J Immunol. 153: 2213
67. Patel R, Terasaki PI (1969) Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280: 735
68. Perlmutter DH, Colten HR (1992) Complement: Molecular Genetics. In: Gallin JI, Goldstein IM, Snyderman R (eds) Inflammation: basic principles and clinical correlates. 2nd edn. Raven Press, New York, pp 81-102
69. Platt JL, Dalmasso AP, Lindman BJ, et al (1991) The role of C5a and antibody in the release of heparan sulfate from endothelial cells. Eur J Immunol 21: 2887
70. Platt JL (2002) C4d and the fate of organ allografts. J Am Soc Nephrol 13: 2417-2419
71. Pober JS, Cotran RZ (1990) The role of endothelial cells in inflammation. Transplantation 50: 537
72. Pratt JR, Basheer SA, Sacks SH (2002) Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 8: 582
73. Qian Z, Jakobs FM, Pfaff-Amesse T, et al (1998) Complement contributes to the rejection of complete and Class I MHC incompatible cardiac allografts. J Heart Lung Transplant 17: 470
74. Qian Z, Wasowska BA, Behrens E, et al (1999) C6 produced by macrophages contributes to cardiac allograft rejection. Amer J Pathol 155: 1293
75. Radio S, Wood S, Wilson J, et al (1996) Allograft vascular disease: comparison of heart and other grafted organs. Transplant Proc 28: 496
76. Ruggeri ZM (1997) von Willebrand factor. J Clin Invest 99: 559
77. Rus HG, Niculescu FI, Shin M (2001) Role of the C5b-9 complement complex in cell cycle and apoptosis. Immunol Rev 180: 49
78. Saadi S, Holzknecht RA, Patte CP, et al (1995) Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med 182: 1807
79. Saadi S, Holzknecht RA, Patte CP, et al (2000) Endothelial cell activation by pore-forming structures: pivotal role for interleukin-1 alpha. Circulation 101: 1867
80. Selvan RS, Kapadia HB, Platt JL (1998) Complement-induced expression of chemokine genes in endothelium: regulation by IL-1-dependent and -independent mechanisms. J Immunol 161: 4388-4395
81. Sims PJ, Wiedmer T (1995) Induction of cellular procoagulant activity by the membrane attack complex of complement. Semin Cell Biol 6: 275
82. Taylor PR, Carugati A, Fadok VA, et al (2000) A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med 192: 359-366
83. Tedesco F, Pausa M, Nardon E, et al (1997) The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J Exp Med 185: 1619
84. Theruvath TP, Saidman SL, Mauiyyedi S, et al (2001) Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. Transplantation 72: 77
85. Trpkov K, Campbell P, Pazaderka F, et al (1996) Pathologic features of acute renal allograft rejection associated with donor-specific antibody: Analysis using the Banff grading schema. Transplantation 61: 1586
86. Tsuji RF, Kawikova I, Ramabhadran R, et al (2000) Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J Immunol 165: 1588
87. Vakeva A, Laurila P, Meri S (1993) Regulation of complement membrane attack complex formation in myocardial infarction. Am J Pathol 143: 65
88. Vakeva A, Morgan BP, Tikkanen I, et al (1994) Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium. Am J Pathol 144: 1357
89. Van den Berg RH, Faber-Krol MC, Sim RB, et al (1998) The first subcomponent of complement, Clq, triggers the production of IL-8, IL-6, and monocyte chemoattractant peptide-1 by human umbilical vein endothelial cells. J Immunol 161: 6924
90. Van den Elsen JMH, Martin A, Wong V, et al (2002) X-ray crystal structure of the C4d fragment of human complement component C4. J Mol Biol 322: 1103
91. Weiser MR, Williams JP, Moore FD Jr, et al (1996) Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 183: 2343
92. Weisman HF, Bartow T, Leppo MK, et al (1990) Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249: 146
93. Weyrich AS, McIntyre TM, McEver RP, et al (1995) Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. J Clin Invest 95: 2297
94. Weyrich AS, Elstad MR, McEver RP, et al (1996) Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 97: 1525
95. Williams GM, Hume DM, Hudson RP Jr, et al (1968) "Hyperacute" renal-homograft rejection in man. N Engl J Med 279: 611
96. Wolbink GJ, Brouwer MC, Buysmann S, et al (1996) CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. J Immunol 157: 473
97. Yasojima K, Schwab C, McGeer EG, et al (1998) Human heart generates complement proteins that are upregulated and activated after myocardial infarction. Circ Res 83: 860
98. Yasojima K, Schwab C, McGeer EG, et al (2001) Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 158: 1039
99. Young-Ramsaran JO, Hruban RH, Hutchins GM, et al (1993) Ultrastructural evidence of cell-mediated endothelial cell injury in cardiac transplant-related accelerated arteriosclerosis. Ultrastruct Pathol 17: 125
100. Zhou W, Farrar CA, Abe K, et al (2000) Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 105: 1363